samedan logo
 
 
 
spacer
home > ebr > summer 2003 > giving vaccines the boost they need
PUBLICATIONS
European Biopharmaceutical Review

Giving Vaccines the Boost They Need

Estimated revenues for therapeutic biologics are set to grow to $50 billion per annum, with immunotherapeutics predicted to grow to 10 per cent of the prescription drug market ($40 billion) within the next decade. Creating immunotherapeutics for diseases such as cancer however, represents a significant challenge for the industry. For example cancer vaccines have to overcome 'self tolerance', the immune system's in-built reluctance to attack its own cells.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Deirdre Gillespie, President and Chief Executive Officer at Oxxon PharmaccinesTM Ltd

Dr Deirdre Gillespie is President and Chief Executive Officer of Oxxon PharmaccinesTM Ltd, a biotechnology company developing innovative immunotherapeutics, specifically therapeutic vaccines (pharmaccines), for the treatment of chronic infectious diseases and cancer. While at Oxxon, Deirdre has overseen the progression of the company's pharmaccines for the treatment of Hepatitis B and malignant melanoma into Phase II clinical trials.

Deirdre was also instrumental in a recently announced private financing that saw Oxxon raise £15 million in an international funding round. She has 16 years' experience in the pharmaceutical and biotechnology industries including senior positions at Vical Inc and DuPont Merck Pharmaceutical Company. Deirdre gained a medical degree from London University and an MBA from London Business School.

spacer
Dr Deirdre Gillespie
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Automated Enzyme Analyzers Streamline Enzyme Assay Applications

SUNNYVALE, Calif. – (September 16, 2021) – Multi-enzyme analysis can now be achieved through a single, fully-automated enzyme analyzer, benefitting industrial enzyme manufacturers and enzyme users in the food, beverage, biopharmaceutical, fuel ethanol and chemical, and solid waste management industries.
More info >>

White Papers

Blockbuster Drugs Need Blockbuster Components

West Pharmaceutical Services, Inc.

Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement